CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization.

Source:http://linkedlifedata.com/resource/pubmed/id/19008380

Download in:

View as

General Info

PMID
19008380